Previous close | 160.40 |
Open | 160.71 |
Bid | 160.11 x 800 |
Ask | 161.22 x 1000 |
Day's range | 160.35 - 161.44 |
52-week range | 130.96 - 182.89 |
Volume | |
Avg. volume | 5,658,393 |
Market cap | 283.864B |
Beta (5Y monthly) | 0.59 |
PE ratio (TTM) | 47.84 |
EPS (TTM) | 3.36 |
Earnings date | 25 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | 6.20 (3.86%) |
Ex-dividend date | 12 Apr 2024 |
1y target est | 182.41 |
Ironwood (IRWD) incurs loss in the first quarter of 2024. Revenues decline year over year and miss estimates. The company lowers revenue guidance for 2024. Stock falls.
Shares of Teva Pharmaceutical Industries were climbing yet again on Wednesday, after the company announced positive results in a trial of a schizophrenia medicine. Its quarterly results, also disclosed early Wednesday, were mixed. Revenue was $3.8 billion for the quarter, slightly better than the FactSet consensus estimate of $3.7 billion, while non-GAAP diluted earnings were 48 cents a share.